Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
(Source: Trials)
Source: Trials - February 15, 2022 Category: Research Source Type: clinical trials
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Condition: Influenza Interventions: Drug: Baloxavir Marboxil; Drug: Placebo; Drug: Oseltamivir Sponsors: Weill Medical College of Cornell University; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir
Condition: Drug-drug Interaction Interventions: Drug: ZSP1273; Drug: Oseltamivir Sponsor: Guangdong Raynovent Biotech Co., Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2021 Category: Research Source Type: clinical trials